Diabetes technology

Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective

Diabetes Obes MetabPublished Cost–utility analysis

Main finding · Cost-utility (ICER)Result — go to the resultICER 10 556 €/QALY

Authors' conclusion

From an Italian healthcare system perspective, flash CGM is cost effective compared with SMBG for people living with T2DM on basal insulin.

Study context

Population
People with T2D receiving basal insulin; simulated patient characteristics reflecting Italian population data
Participants
10,000 simulated patients
Comparison
Flash continuous glucose monitoring (CGM) vs self-monitoring of blood glucose (SMBG)
Outcome
Cost-utility: incremental cost per QALY (ICER)
Follow-up
Lifetime horizon
Methodological detailspatient-level microsimulation model, Italian healthcare system perspective, lifetime horizon, 3.0% discounting for costs and utilities, probabilistic and scenario analyses, Inputs based on clinical trials and real-world evidence
  • Patient-level microsimulation model
  • Italian healthcare system perspective
  • Lifetime horizon
  • 3.0% discounting for costs and utilities
  • Probabilistic and scenario analyses
  • Inputs based on clinical trials and real-world evidence

Main finding

Cost-utility (ICER) · lifetime

Incremental cost-effectiveness ratio (ICER)

10 556 €/QALY

As reported in the abstract

Direct costs higher with flash CGM vs SMBG
€5338
More quality-adjusted life-years (QALYs) with flash CGM vs SMBG
0.51

Further findings

Scenario analysis ICERs

ICER range across scenarios
€3825/QALY to €26 737/QALY

Probabilistic analysis

Probability flash CGM cost effective at willingness-to-pay thresholds > €20 000/QALY
100%

Original publication

Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective. Diabetes Obes Metab. Published 10 June 2024. doi:10.1111/dom.15703

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.